Abeona Therapeutics

abeonatherapeutics.com

Abeona Therapeutics Inc. is focused on delivering innovative cell and gene therapies for serious diseases, particularly genetic disorders. The company is developing gene therapy-based potential cures for conditions like Recessive Dystrophic Epidermolysis Bullosa (RDEB) and genetic eye disorders. With a robust pipeline and a fully-operational manufacturing facility, Abeona is well-positioned in the biotechnology sector, leveraging its expertise in gene and cell therapy development. The company aims to transform patient care by making cures the new standard, supported by its AIM Vector Platform, which includes over 100 next-generation AAV capsids for targeted gene delivery.